Seres Therapeutics IncNASDAQ:MCRBNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.6884
- TODAY'S CHANGE (%)0.1095 (18.9152%)
- Bid / Lots0.6850/ 5
- Ask / Lots0.6992/ 4
- Open / Previous Close0.5818 / 0.5789
- Day Range
- 52 Week Range
- Volume4,401,742
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MCRB |
|---|---|---|
| 09:32 ET | 84742 | 0.5895 |
| 09:33 ET | 12100 | 0.5881 |
| 09:35 ET | 4982 | 0.5882 |
| 09:37 ET | 20613 | 0.585849 |
| 09:39 ET | 46514 | 0.5895 |
| 09:42 ET | 34219 | 0.59585 |
| 09:44 ET | 6100 | 0.5996 |
| 09:46 ET | 28616 | 0.60495 |
| 09:48 ET | 3600 | 0.604 |
| 09:50 ET | 1904 | 0.604 |
| 09:51 ET | 16127 | 0.6035 |
| 09:53 ET | 26532 | 0.61 |
| 09:55 ET | 14882 | 0.6086 |
| 09:57 ET | 4142 | 0.6106 |
| 10:00 ET | 13400 | 0.6145 |
| 10:02 ET | 18784 | 0.61105 |
| 10:04 ET | 62461 | 0.62 |
| 10:06 ET | 8942 | 0.6197 |
| 10:08 ET | 4281 | 0.62 |
| 10:09 ET | 29144 | 0.63 |
| 10:11 ET | 26914 | 0.6244 |
| 10:13 ET | 32338 | 0.6257 |
| 10:15 ET | 28865 | 0.6286 |
| 10:18 ET | 26453 | 0.6322 |
| 10:20 ET | 10776 | 0.631859 |
| 10:22 ET | 22607 | 0.6311 |
| 10:24 ET | 6053 | 0.6356 |
| 10:26 ET | 26781 | 0.6317 |
| 10:27 ET | 11221 | 0.6369 |
| 10:29 ET | 14488 | 0.63645 |
| 10:31 ET | 18547 | 0.639 |
| 10:33 ET | 19892 | 0.6389 |
| 10:36 ET | 24043 | 0.639 |
| 10:38 ET | 12060 | 0.63845 |
| 10:40 ET | 5803 | 0.6389 |
| 10:42 ET | 18530 | 0.638949 |
| 10:44 ET | 29857 | 0.63565 |
| 10:45 ET | 28313 | 0.6383 |
| 10:47 ET | 4234 | 0.64 |
| 10:49 ET | 4095 | 0.64 |
| 10:51 ET | 34919 | 0.6435 |
| 10:54 ET | 17328 | 0.637 |
| 10:56 ET | 4153 | 0.639 |
| 10:58 ET | 13327 | 0.6423 |
| 11:00 ET | 45307 | 0.6414 |
| 11:02 ET | 3080 | 0.6407 |
| 11:03 ET | 4439 | 0.6429 |
| 11:05 ET | 8054 | 0.6424 |
| 11:07 ET | 5835 | 0.644 |
| 11:09 ET | 8519 | 0.644 |
| 11:12 ET | 19135 | 0.6465 |
| 11:14 ET | 10664 | 0.6485 |
| 11:16 ET | 27079 | 0.6486 |
| 11:18 ET | 6818 | 0.6497 |
| 11:20 ET | 23849 | 0.65 |
| 11:21 ET | 13395 | 0.6516 |
| 11:23 ET | 10874 | 0.6494 |
| 11:25 ET | 7726 | 0.6527 |
| 11:27 ET | 14938 | 0.6511 |
| 11:30 ET | 10323 | 0.651 |
| 11:32 ET | 9536 | 0.652 |
| 11:34 ET | 5491 | 0.6537 |
| 11:36 ET | 5929 | 0.6531 |
| 11:38 ET | 9691 | 0.6549 |
| 11:39 ET | 19944 | 0.65715 |
| 11:41 ET | 23686 | 0.662 |
| 11:43 ET | 17751 | 0.6611 |
| 11:45 ET | 7885 | 0.6599 |
| 11:48 ET | 30723 | 0.6543 |
| 11:50 ET | 44250 | 0.656 |
| 11:52 ET | 13351 | 0.6606 |
| 11:54 ET | 19322 | 0.6602 |
| 11:56 ET | 12002 | 0.6618 |
| 11:57 ET | 8246 | 0.6618 |
| 11:59 ET | 6049 | 0.6604 |
| 12:01 ET | 49847 | 0.6618 |
| 12:03 ET | 6989 | 0.6609 |
| 12:06 ET | 6256 | 0.6625 |
| 12:08 ET | 11734 | 0.663 |
| 12:10 ET | 29333 | 0.6699 |
| 12:12 ET | 28055 | 0.6698 |
| 12:14 ET | 127019 | 0.68 |
| 12:15 ET | 51576 | 0.6796 |
| 12:17 ET | 8465 | 0.68 |
| 12:19 ET | 5802 | 0.6799 |
| 12:21 ET | 34346 | 0.6773 |
| 12:24 ET | 7260 | 0.6799 |
| 12:26 ET | 81637 | 0.6785 |
| 12:28 ET | 125174 | 0.69 |
| 12:30 ET | 110704 | 0.68755 |
| 12:32 ET | 140363 | 0.69 |
| 12:33 ET | 17384 | 0.6884 |
| 12:35 ET | 6307 | 0.6899 |
| 12:37 ET | 47080 | 0.6894 |
| 12:39 ET | 29051 | 0.6913 |
| 12:42 ET | 48991 | 0.6886 |
| 12:44 ET | 34436 | 0.67745 |
| 12:46 ET | 57236 | 0.678 |
| 12:48 ET | 13618 | 0.68 |
| 12:50 ET | 27364 | 0.6795 |
| 12:51 ET | 66836 | 0.6714 |
| 12:53 ET | 66533 | 0.6618 |
| 12:55 ET | 13748 | 0.6628 |
| 12:57 ET | 6125 | 0.6611 |
| 01:00 ET | 12391 | 0.6615 |
| 01:02 ET | 129347 | 0.6531 |
| 01:04 ET | 3185 | 0.6546 |
| 01:06 ET | 78909 | 0.6482 |
| 01:08 ET | 7560 | 0.651799 |
| 01:09 ET | 6355 | 0.6523 |
| 01:11 ET | 18605 | 0.6546 |
| 01:13 ET | 20683 | 0.6607 |
| 01:15 ET | 8403 | 0.6623 |
| 01:18 ET | 5557 | 0.6632 |
| 01:20 ET | 3920 | 0.6628 |
| 01:22 ET | 31903 | 0.66 |
| 01:24 ET | 16098 | 0.6618 |
| 01:26 ET | 8859 | 0.6643 |
| 01:27 ET | 3380 | 0.6652 |
| 01:29 ET | 31739 | 0.6621 |
| 01:31 ET | 6086 | 0.6656 |
| 01:33 ET | 3810 | 0.6628 |
| 01:36 ET | 3671 | 0.6665 |
| 01:38 ET | 3014 | 0.665 |
| 01:40 ET | 11946 | 0.6635 |
| 01:42 ET | 5277 | 0.6642 |
| 01:44 ET | 3748 | 0.6633 |
| 01:45 ET | 7191 | 0.6641 |
| 01:47 ET | 2690 | 0.6641 |
| 01:49 ET | 1950 | 0.6641 |
| 01:51 ET | 21122 | 0.6618 |
| 01:54 ET | 3488 | 0.6628 |
| 01:56 ET | 3018 | 0.6641 |
| 01:58 ET | 2796 | 0.6641 |
| 02:00 ET | 3770 | 0.6641 |
| 02:02 ET | 7672 | 0.662901 |
| 02:03 ET | 26162 | 0.6531 |
| 02:05 ET | 4147 | 0.656 |
| 02:07 ET | 7889 | 0.6519 |
| 02:09 ET | 3300 | 0.6556 |
| 02:12 ET | 6210 | 0.6556 |
| 02:14 ET | 9911 | 0.6566 |
| 02:16 ET | 1700 | 0.6639 |
| 02:18 ET | 129598 | 0.6659 |
| 02:20 ET | 30590 | 0.6642 |
| 02:21 ET | 7288 | 0.6627 |
| 02:23 ET | 3002 | 0.6649 |
| 02:25 ET | 1812 | 0.6671 |
| 02:27 ET | 7829 | 0.66555 |
| 02:30 ET | 9949 | 0.6682 |
| 02:32 ET | 12374 | 0.6672 |
| 02:34 ET | 190195 | 0.6851 |
| 02:36 ET | 4013 | 0.6796 |
| 02:38 ET | 12533 | 0.6826 |
| 02:39 ET | 2304 | 0.6785 |
| 02:41 ET | 2464 | 0.6772 |
| 02:43 ET | 2966 | 0.6814 |
| 02:45 ET | 15393 | 0.681 |
| 02:48 ET | 17988 | 0.6816 |
| 02:50 ET | 7212 | 0.6792 |
| 02:52 ET | 8644 | 0.68 |
| 02:54 ET | 3077 | 0.681 |
| 02:56 ET | 26642 | 0.681 |
| 02:57 ET | 3452 | 0.6808 |
| 02:59 ET | 73030 | 0.691799 |
| 03:01 ET | 7750 | 0.6936 |
| 03:03 ET | 10210 | 0.69005 |
| 03:06 ET | 5726 | 0.6927 |
| 03:08 ET | 38602 | 0.69 |
| 03:10 ET | 5167 | 0.6927 |
| 03:12 ET | 12416 | 0.6926 |
| 03:14 ET | 38254 | 0.6927 |
| 03:15 ET | 3535 | 0.6944 |
| 03:17 ET | 9920 | 0.6901 |
| 03:19 ET | 4582 | 0.6908 |
| 03:21 ET | 13320 | 0.690208 |
| 03:24 ET | 7146 | 0.691 |
| 03:26 ET | 12428 | 0.6906 |
| 03:28 ET | 6029 | 0.6842 |
| 03:30 ET | 10282 | 0.68653 |
| 03:32 ET | 25514 | 0.688349 |
| 03:33 ET | 20061 | 0.68595 |
| 03:35 ET | 4550 | 0.6888 |
| 03:37 ET | 12120 | 0.6909 |
| 03:39 ET | 6950 | 0.6917 |
| 03:42 ET | 9278 | 0.6951 |
| 03:44 ET | 11716 | 0.6912 |
| 03:46 ET | 7321 | 0.6918 |
| 03:48 ET | 7415 | 0.6928 |
| 03:50 ET | 9814 | 0.6958 |
| 03:51 ET | 14652 | 0.6963 |
| 03:53 ET | 11401 | 0.69 |
| 03:55 ET | 58104 | 0.69 |
| 03:57 ET | 37799 | 0.6884 |
| 04:00 ET | 150919 | 0.6884 |
Nov 14, 2024
DJ Seres Therapeutics Is Maintained at Buy by Canaccord Genuity, from 11:20AM ET on Thursday Nov 14, 2024 by Dow Jones
11:20AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
DJ Seres Therapeutics Is Maintained at Buy by Chardan Capital, from 7:06PM ET on Wednesday Nov 13, 2024 by Dow Jones
7:06PM ET on Wednesday Nov 13, 2024 by Dow Jones*DJ Seres Therapeutics 3Q EPS 58c >MCRB, from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 13, 2024 by Dow JonesSeres Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates, from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 6, 2024
Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024, from 7:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Seres Therapeutics Inc | 98.5M | -0.6x | --- |
Heron Therapeutics Inc | 177.5M | -6.5x | --- |
Karyopharm Therapeutics Inc | 99.6M | -1.0x | --- |
Spero Therapeutics Inc | 61.6M | 19.0x | --- |
CytomX Therapeutics Inc | 67.6M | 5.3x | --- |
FibroGen Inc | 33.9M | -0.3x | --- |
Company Information
Seres Therapeutics, Inc. is a clinical-stage company focused on improving patient outcomes in medically vulnerable populations through novel live biotherapeutics. The Company is engaged in developing SER-155, which has demonstrated a significant reduction in bloodstream infections and related complications (as compared to placebo) in a clinical study in patients undergoing allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT). The Company is also advancing additional cultivated oral live biotherapeutics for medically vulnerable populations, including those with chronic liver disease, cancer neutropenia, and solid organ transplants. The Company's clinical and nonclinical data across its programs support the development of live biotherapeutics to target the prevention and treatment of a broad swath of infections, and in inflammatory and immune diseases.
Contact Information
- Headquarters
- 101 Cambridge Park DriveCAMBRIDGE, MA, United States 02140
- Phone
- 617-945-9626
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Stephen Berenson
- President, Chief Executive Officer, Director
- Eric Shaff
- Chief Financial Officer, Executive Vice President
- Marella Thorell
- Executive Vice President, Chief Technology Officer
- David Ege
- Executive Vice President, Chief Scientific Officer
- Matthew Henn
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $98.5M |
|---|---|
Revenue (TTM) | $64.0K |
Shares Outstanding | 170.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.99 |
EPS | $-1.14 |
Book Value | $-0.33 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 1,539.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -218,167.20% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
